Código 293624 (Harmonized System 2012 by 6 digits)
2023: US$16M, Total Trade Exchange
2023: US$338k, International Sales
2023: US$15.7M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins was US$16M.
In 2023, the states with the most international sales in D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were Jalisco (US$103k).
The states with the most international purchases in 2023 were Jalisco (US$8.29M), Ciudad de México (US$3.2M), Querétaro (US$2.08M), Estado de México (US$132k), and Guanajuato (US$49k).
In the global context, the main exporting countries of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins in 2022 were China (US$311M), United Kingdom (US$116M), and Netherlands (US$106M). In the same year, the main importing countries of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were United States (US$99M), Netherlands (US$46M), and Belgium (US$41.3M).
US$16M, Total Trade Exchange (2023)
In 2023, the total trade exchange of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins in Mexico (including international purchases and sales) was US$16M.
The visualizations show the net balance of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
July, 2024: US$530k, International Purchases
In July 2024, international sales of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were US$0, while international purchases reached US$530k. The above results in a trade balance of -US$530k.
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were China (US$311M), United Kingdom (US$116M), and Netherlands (US$106M). In the same year, the main importing countries for D-Pantothenic Acid or Dl "Vitamin B3 or Vitamin B5" and Derivatives Thereof Used Primarily as Vitamins were United States (US$99M), Netherlands (US$46M), and Belgium (US$41.3M).